Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02155491 · ClinicalTrials.gov registry record
Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events
A clinical trial of Pulmonary Embolism and Venous Thromboembolism, sponsored by Thrombosis Research Institute.
- Completed
- Registry status
- 10,679
- Enrollment target
- 1
- Study location
NCT02155491 is a study of Pulmonary Embolism and Venous Thromboembolism that has completed, run by Thrombosis Research Institute. The registered enrollment target is 10,679 participants, above the 2,836-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (277% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02155491, a study of Pulmonary Embolism and Venous Thromboembolism, has completed, sponsored by Thrombosis Research Institute.
- COMPLETED
- Registry status
- 10,679 participants
- Enrollment target
- 1
- Study location
Study Summary
The protocol is a large registry to describe acute, sub-acute and extended duration of anticoagulation management, clinical and economic duration of anticoagulation management, clinical and economic outcomes in patients with treated acute VTE (DVT and PE) in the real-world setting. Main objectives are to clarify the: * treatment related details for acute VTE (either conventional anticoagulation therapy, treatment with a direct oral anti-coagulant or other modalities of treatment) * Rate of early and late symptomatic VTE recurrence * Rate and nature of complications of VTE including post thrombotic syndrome and chronic thromboembolic pulmonary hypertension * Rate of bleeding complications * Rate of all-cause mortality at six months
Conditions Studied
Study Locations (1)
Alabama
- Dr Terence Hart - Muscle Shoals
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,679 participants |
| Start Date | 2014-07-07 |
| Est. Completion | 2020-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02155491
The ClinicalTrials.gov registry entry for NCT02155491 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10,679 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,836-participant average among 48 other Pulmonary Embolism trials with a reported enrollment target (277% higher). The listed sponsor is Thrombosis Research Institute, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Pulmonary Embolism appearing as the primary indexed condition, and to 0 interventions.
NCT02155491 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.
Frequently Asked Questions
What is clinical trial NCT02155491 about?
NCT02155491 is a clinical study titled "Global Anticoagulant Registry in the FIELD- Venous Thromboembolic Events". The protocol is a large registry to describe acute, sub-acute and extended duration of anticoagulation management, clinical and economic duration of anticoagulation management, clinical and economic outcomes in patients with treated acute VTE (DVT and PE) in the real-world setting. Main objectives ...
What is the current status of trial NCT02155491?
This trial is currently completed. The enrollment target is 10,679 participants. The study started on 2014-07-07. Estimated completion is 2020-09-30.
What conditions does trial NCT02155491 study?
This clinical trial studies the following conditions: Pulmonary Embolism, Venous Thromboembolism, Deep Vein Thrombosis.
Who is sponsoring clinical trial NCT02155491?
This trial is sponsored by Thrombosis Research Institute, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02155491 being conducted?
This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Embolism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Mobility Outcomes in Post-Pulmonary Embolic Disease
RECRUITING · NA
-
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
RECRUITING · NA
-
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU
RECRUITING · NA
-
The PERSEVERE Study
RECRUITING · NA
-
Point-of-Care Ultrasound in Predicting Adverse Outcomes in Emergency Department Patients With Acute Pulmonary Embolism
RECRUITING
-
Supplemental Oxygen in Pulmonary Embolism (SO-PE)
RECRUITING · Early Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.